易化型葡萄糖转运体的表达、分布及相关疾病的研究进展
|
摘要
易化型葡萄糖转运体(glucose transporters, GLUT)是指以易化扩散形式介导葡萄糖跨膜转运的蛋白,对细胞能量代谢调控至关重要,近年相关研究甚多。目前已知易化型GLUT亚型有14种,其分布和生理功能存在明显的组织特异性。本文就14种易化型GLUT亚型的组织细胞分布、亚细胞定位、表达调控、主要作用以及与疾病发生的关系等进行总结,以助于深入理解易化型GLUT亚型的生理与病理生理意义。
Facilitative glucose transporters(GLUT) are proteins that mediate glucose transmembrane transport in the form of facilitated diffusion, which play an important role in regulating cell energy metabolism. There are many breakthroughs in researches of facilitative GLUT in recent years. It has been known that there are 14 subtypes of facilitative GLUT with obvious tissue specificity in distribution and physiological function. In the present review, the tissue and cellular distribution, subcellular localization, expression regulation, physiological function and the relationship to diseases of facilitative GLUT subtypes were summarized, in order to further understand their physiological and pathophysiological significances.
Facilitative glucose transporters(GLUT) are proteins that mediate glucose transmembrane transport in the form of facilitated diffusion, which play an important role in regulating cell energy metabolism. There are many breakthroughs in researches of facilitative GLUT in recent years. It has been known that there are 14 subtypes of facilitative GLUT with obvious tissue specificity in distribution and physiological function. In the present review, the tissue and cellular distribution, subcellular localization, expression regulation, physiological function and the relationship to diseases of facilitative GLUT subtypes were summarized, in order to further understand their physiological and pathophysiological significances.
引文
[1] Yan N.A glimpse of membrane transport through structures-advances in the structural biology of the GLUTglucose transporters.J Mol Biol 2017;429(17):2710-2725.
2 Thorens B,Mueckler M.Glucose transporters in the 21st century.Am J Physiol Endocrinol Metab 2010;298(2):E141-E145.
3 Mueckler M,Thorens B.The SLC2(GLUT)family of membrane transporters.Mol Aspects Med 2013;34(2-3):121-138.
4 Jaldin-Fincati JR,Pavarotti M,Frendo-Cumbo S,Bilan PJ,Klip A.Update on GLUT4 vesicle traffic:a cornerstone of insulin action.Trends Endocrinol Metab 2017;28(8):597-611.
5 Gamberucci A,Marcolongo P,Nemeth CE,Zoppi N,Szarka A,Chiarelli N,Hegedus T,Ritelli M,Carini G,Willaert A,Callewaert BL,Coucke PJ,Benedetti A,Margittai E,Fulceri R,Banhegyi G,Colombi M.GLUT10-lacking in arterial tortuosity syndrome-is localized to the endoplasmic reticulum of human fibroblasts.Int J Mol Sci 2017;18(8).pii:E1820.doi:10.3390/ijms18081820.
6 Mueckler M.Facilitative glucose transporters.Eur JBiochem 1994;219(3):713-725.
7 Ge X,Chen C,Hui X,Wang Y,Lam KS,Xu A.Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes.J Biol Chem 2011;286(40):34533-34541.
8 Lu CS,Ye RG,Yang QQ,Yang X,Li HQ,Li YJ.Gene expression of glucose transports and its regulation by glucose in mesothelial cells.Chin Med J 2001;114(5):477-480.
9 Hsieh IS,Yang RS,Fu WM.Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.PLoS One 2014;9(10):e109550.
10 Romero R,Casanova B,Pulido N,Suarez AI,Rodriguez E,Rovira A.Stimulation of glucose transport by thyroid hormone in 3T3-L1 adipocytes:increased abundance of GLUT1 and GLUT4 glucose transporter proteins.J Endocrinol 2000;164(2):187-195.
11 Huang Y,Lei L,Liu D,Jovin I,Russell R,Johnson RS,Di Lorenzo A,Giordano FJ.Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alphad e pendent function.Proc Natl Acad Sci U S A 2012;109(43):17478-17483.
12 Chiou GY,Fong JC.Prostaglandin F2alpha increases glucose transport in 3T3-L1 adipocytes through enhanced GLUT1 expression by a protein kinase C-dependent pathway.Cell Signal 2004;16(4):415-421.
13 Hiraki Y,McMorrow IM,Birnbaum MJ.The regulation of glucose transporter gene expression by cyclic adenosine monophosphate in NIH3T3 fibroblasts.Mol Endocrinol1989;3(9):1470-1476.
14 Mountjoy KG,Flier JS.Vanadate regulates glucose transporter(Glut-1)expression in NIH3T3 mouse fibroblasts.Endocrinology 1990;127(4):2025-2034.
15 Rollins BJ,Morrison ED,Usher P,Flier JS.Platelet-derived growth factor regulates glucose transporter expression.JBiol Chem 1988;263(32):16523-16526.
16 Takano M,Rhoads DB,Isselbacher KJ.Sodium butyrate increases glucose transporter expression in LLC-PK1 cells.Proc Natl Acad Sci U S A 1988;85(21):8072-8075.
17 Diaz M,Vraskou Y,Gutierrez J,Planas JV.Expression of rainbow trout glucose transporters GLUT1 and GLUT4during in vitro muscle cell differentiation and regulation by insulin and IGF-I.Am J Physiol Regul Integr Comp Physiol2009;296(3):R794-R800.
18 Tordjman KM,Leingang KA,James DE,Mueckler MM.Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes:effect of chronic insulin and tolbutamide treatment.Proc Natl Acad Sci U S A1989;86(20):7761-7765.
19 Tai PK,Liao JF,Chen EH,Dietz J,Schwartz J,Carter-Su C.Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells.J Biol Chem 1990;265(35):21828-21834.
20 Stephens JM,Carter BZ,Pekala PH,Malter JS.Tumor necrosis factor alpha-induced glucose transporter(GLUT-1)mRNA stabilization in 3T3-L1 preadipocytes.Regulation by the adenosine-uridine binding factor.J Biol Chem 1992;267(12):8336-8341.
21 Spolcova A,Holubova M,Mikulaskova B,Nagelova V,Stofkova A,Lacinova Z,Jurcovicova J,Haluzik M,Maletinska L,Zelezna B.Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes.Physiol Res 2014;63(4):483-490.
22 Nagai K,Inoue T,Konishi H.Increased gene expression of glucose transporters in the mouse brain after treatment with fluoxetine and pergolide.Drug Res(Stuttg)2014;64(7):389-391.
23 Walker PS,Ramlal T,Donovan JA,Doering TP,Sandra A,Klip A,Pessin JE.Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line.J Biol Chem 1989;264(11):6587-6595.
24 Schwartzenberg-Bar-Yoseph F,Armoni M,Karnieli E.The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.Cancer Res 2004;64(7):2627-2633.
25 Delahayes JF.Depolarization-induced movement of Mn 2cations across the cell membrane in the guinea pig myocardium.Circ Res 1975;36(6):713-718.
26 Narasimhan A,Chinnaiyan M,Karundevi B.Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat.Eur J Pharmacol 2015;761:391-397.
27 Postic C,Burcelin R,Rencurel F,Pegorier JP,Loizeau M,Girard J,Leturque A.Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver:studies in vivo and in vitro.Biochem J 1993;293(Pt 1):119-124.
28 Simpson IA,Dwyer D,Malide D,Moley KH,Travis A,Vannucci SJ.The facilitative glucose transporter GLUT3:20 years of distinction.Am J Physiol Endocrinol Metab2008;295(2):E242-E253.
29 Hu H,Xu M,Qi R,Wang Y,Wang C,Liu J,Luo L,Xia L,Fang Z.Sitagliptin downregulates retinol-binding protein 4and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.Int J Clin Exp Med2015;8(10):17902-17911.
30 Armoni M,Harel C,Ramdas M,Karnieli E.CYP2E1impairs GLUT4 gene expression and function:NRF2 as a possible mediator.Horm Metab Res 2014;46(7):477-483.
31 Matosin-Matekalo M,Mesonero JE,Laroche TJ,Lacasa M,Brot-Laroche E.Glucose and thyroid hormone co-regulate the expression of the intestinal fructose transporter GLUT5.Biochem J 1999;339(Pt 2):233-239.
32 Nilsson TH,Richmond CF,Nelson TM.Flicker adaptation shows evidence of many visual channels selectively sensitive to temporal frequency.Vision Res 1975;15(5):621-624.
33 Stuart CA,Howell ME,Yin D.Overexpression of GLUT5in diabetic muscle is reversed by pioglitazone.Diabetes Care 2007;30(4):925-931.
34 Douard V,Ferraris RP.Regulation of the fructose transporter GLUT5 in health and disease.Am J Physiol Endocrinol Metab 2008;295(2):E227-E237.
35 Kim E,Seok HH,Lee SY,Lee DR,Moon J,Yoon TK,Lee WS,Lee KA.Correlation between expression of glucose transporters in granulosa cells and oocyte quality in women with polycystic ovary syndrome.Endocrinol Metab(Seoul)2014;29(1):40-47.
36 Cheeseman C.GLUT7:a new intestinal facilitated hexose transporter.Am J Physiol Endocrinol Metab 2008;295(2):E238-E241.
37 Ibberson M,Riederer BM,Uldry M,Guhl B,Roth J,Thorens B.Immunolocalization of GLUTX1 in the testis and to specific brain areas and vasopressin-containing neurons.Endocrinology 2002;143(1):276-284.
38 Mayer AL,Higgins CB,Heitmeier MR,Kraft TE,Qian X,Crowley JR,Hyrc KL,Beatty WL,Yarasheski KE,Hruz PW,DeBosch BJ.SLC2A8(GLUT8)is a mammalian trehalose transporter required for trehalose-induced autophagy.Sci Rep 2016;6:38586.
39 Schmidt S,Joost HG,Schurmann A.GLUT8,the enigmatic intracellular hexose transporter.Am J Physiol Endocrinol Metab 2009;296(4):E614-E618.
40 Joost HG,Thorens B.The extended GLUT-family of sugar/polyol transport facilitators:nomenclature,sequence characteristics,and potential function of its novel members(review).Mol Membr Biol 2001;18(4):247-256.
41 Kimura T,Takahashi M,Yan K,Sakurai H.Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells.PLoS One 2014;9(1):e84996.
42 Carayannopoulos MO,Schlein A,Wyman A,Chi M,Keembiyehetty C,Moley KH.GLUT9 is differentially expressed and targeted in the preimplantation embryo.Endocrinology2004;145(3):1435-1443.
43 Zhu C,Xu Y,Liu ZH,Wan XC,Li DX,Tai LL.The anti-hyperuricemic effect of epigallocatechin-3-gallate(EGCG)on hyperuricemic mice.Biomed Pharmacother2018;97:168-173.
44 Pujol-Gimenez J,Perez A,Reyes AM,Loo DD,Lostao MP.Functional characterization of the human facilitative glucose transporter 12(GLUT12)by electrophysiological methods.Am J Physiol Cell Physiol 2015;308(12):C1008-C1022.
45 Rogers S,Macheda ML,Docherty SE,Carty MD,Henderson MA,Soeller WC,Gibbs EM,James DE,Best JD.Identification of a novel glucose transporter-like protein-GLUT-12.Am J Physiol Endocrinol Metab 2002;282(3):E733-E738.
46 White MA,Tsouko E,Lin C,Rajapakshe K,Spencer JM,Wilkenfeld SR,Vakili SS,Pulliam TL,Awad D,Nikolos F,Katreddy RR,Kaipparettu BA,Sreekumar A,Zhang X,Cheung E,Coarfa C,Frigo DE.GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaM-KK2 signaling.Endocr Relat Cancer 2018;25(4):453-469.
47 Wu X,Freeze HH.GLUT14,a duplicon of GLUT3,is specifically expressed in testis as alternative splice forms.Genomics 2002;80(6):553-557.
48 Manel N,Kim FJ,Kinet S,Taylor N,Sitbon M,Battini JL.The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.Cell 2003;115(4):449-459.
49 Macintyre AN,Gerriets VA,Nichols AG,Michalek RD,Rudolph MC,Deoliveira D,Anderson SM,Abel ED,Chen BJ,Hale LP,Rathmell JC.The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.Cell Metab 2014;20(1):61-72.
50 Ji XN(姬辛娜),Xu CJ,Gao ZJ,Chen SH,Xu KM,Chen Q.Glucose transporter 1 deficiency syndrome:features of movement disorders,diagnosis and treatment.Chin JContemp Pediatr(中国当代儿科杂志)2018;20(3):209-213(in Chinese with English abstract).
51 Winkler EA,Nishida Y,Sagare AP,Rege SV,Bell RD,Perlmutter D,Sengillo JD,Hillman S,Kong P,Nelson AR,Sullivan JS,Zhao Z,Meiselman HJ,Wendy RB,Soto J,Abel ED,Makshanoff J,Zuniga E,De Vivo DC,Zlokovic BV.GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration.Nat Neurosci2015;18(4):521-530.
52 Deng Y,Li B,Liu Y,Iqbal K,Grundke-Iqbal I,Gong CX.Dysregulation of insulin signaling,glucose transporters,O-GlcNAcylation,and phosphorylation of tau and neurofilaments in the brain:Implication for Alzheimer’s disease.Am J Pathol 2009;175(5):2089-2098.
53 Wang BY,Kalir T,Sabo E,Sherman DE,Cohen C,Burstein DE.Immunohistochemical staining of GLUT1 in benign,hyperplastic,and malignant endometrial epithelia.Cancer2000;88(12):2774-2781.
54 Sasaki H,Shitara M,Yokota K,Hikosaka Y,Moriyama S,Yano M,Fujii Y.Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas.Mol Med Rep 2012;5(3):599-602.
55 Suganuma N,Segade F,Matsuzu K,Bowden DW.Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.BJU Int 2007;99(5):1143-1149.
56 Kapoor S.Glucose transporter 1(GLUT1)and its emerging role as a significant prognostic marker in systemic malignancies.Int J Colorectal Dis 2013;28(9):1317-1318.
57 Saigusa S,Toiyama Y,Tanaka K,Okugawa Y,Fujikawa H,Matsushita K,Uchida K,Inoue Y,Kusunoki M.Prognostic significance of glucose transporter-1(GLUT1)gene expression in rectal cancer after preoperative chemoradiotherapy.Surg Today 2012;42(5):460-469.
58 Hodgkinson AD,Millward BA,Demaine AG.Polymorphisms of the glucose transporter(GLUT1)gene are associated with diabetic nephropathy.Kidney Int 2001;59(3):985-989.
59 Fernandes R,Carvalho AL,Kumagai A,Seica R,Hosoya K,Terasaki T,Murta J,Pereira P,Faro C.Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.Mol Vis2004;10(74-75):618-628.
60 Garg M,Thamotharan M,Becker DJ,Devaskar SU.Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1(GLUT1).Pediatr Diabetes 2014;15(7):511-518.
61 Kellett GL,Brot-Laroche E,Mace OJ,Leturque A.Sugar absorption in the intestine:the role of GLUT2.Annu Rev Nutr 2008;28:35-54.
62 Kehar M,Bijarnia S,Ellard S,Houghton J,Saxena R,Verma IC,Wadhwa N.Fanconi-Bickel syndrome-mutation in SLC2A2 gene.Indian J Pediatr 2014;81(11):1237-1239.
63 Santer R,Steinmann B,Schaub J.Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport.Curr Mol Med 2002;2(2):213-227.
64 Shi PP(史佩佩),Wang M,Dou WJ.Fanconi-Bickel syndrome with SLC2A2 gene mutation in a child.Chin JPediatr(中华儿科杂志)2018;56(1):65-66(in Chinese with English abstract).
65 Chankiewitz E,Peschke D,Herberg L,Bazwinsky I,Muhlbauer E,Bromme HJ,Peschke E.Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse(NZO/Hl)?Exp Clin Endocrinol Diabetes 2006;114(5):262-269.
66 Kiraly MA,Bates HE,Kaniuk NA,Yue JT,Brumell JH,Matthews SG,Riddell MC,Vranic M.Swim training prevents hyperglycemia in ZDF rats:mechanisms involved in the partial maintenance of beta-cell function.Am J Physiol Endocrinol Metab 2008;294(2):E271-E283.
67 Frese T,Bazwinsky I,Muhlbauer E,Peschke E.Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats.Horm Metab Res 2007;39(8):567-574.
68 Agostini M,Romeo F,Inoue S,Niklison-Chirou MV,Elia AJ,Dinsdale D,Morone N,Knight RA,Mak TW,Melino G.Metabolic reprogramming during neuronal differentiation.Cell Death Differ 2016;23(9):1502-1514.
69 Morea V,Bidollari E,Colotti G,Fiorillo A,Rosati J,De Filippis L,Squitieri F,Ilari A.Glucose transportation in the brain and its impairment in Huntington disease:one more shade of the energetic metabolism failure?Amino Acids2017;49(7):1147-1157.
70 Vittori A,Breda C,Repici M,Orth M,Roos RA,Outeiro TF,Giorgini F,Hollox EJ.Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington’s disease.Hum Mol Genet 2014;23(12):3129-3137.
71 Covarrubias-Pinto A,Moll P,Solis-Maldonado M,Acuna AI,Riveros A,Miro MP,Papic E,Beltran FA,Cepeda C,Concha,II,Brauchi S,Castro MA.Beyond the redox imbalance:Oxidative stress contributes to an impaired GLUT3modulation in Huntington’s disease.Free Radic Biol Med2015;89:1085-1096.
72 Szablewski L.Glucose transporters in brain:in health and in Alzheimer’s disease.J Alzheimers Dis 2017;55(4):1307-1320.
73 An Y,Varma VR,Varma S,Casanova R,Dammer E,Pletnikova O,Chia CW,Egan JM,Ferrucci L,Troncoso J,Levey AI,Lah J,Seyfried NT,Legido-Quigley C,O’Brien R,Thambisetty M.Evidence for brain glucose dysregulation in Alzheimer’s disease.Alzheimers Dement 2018;14(3):318-329.
74 James DE,Brown R,Navarro J,Pilch PF.Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein.Nature 1988;333(6169):183-185.
75 Zong H,Wang CC,Vaitheesvaran B,Kurland IJ,Hong W,Pessin JE.Enhanced energy expenditure,glucose utilization,and insulin sensitivity in VAMP8 null mice.Diabetes2011;60(1):30-38.
76 Stenbit AE,Tsao TS,Li J,Burcelin R,Geenen DL,Factor SM,Houseknecht K,Katz EB,Charron MJ.GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes.Nat Med 1997;3(10):1096-1101.
77 Klip A.The many ways to regulate glucose transporter 4.Appl Physiol Nutr Metab 2009;34(3):481-487.
78 Reno CM,Puente EC,Sheng Z,Daphna-Iken D,Bree AJ,Routh VH,Kahn BB,Fisher SJ.Brain GLUT4 knockout mice have impaired glucose tolerance,decreased insulin sensitivity,and impaired hypoglycemic counterregulation.Diabetes 2017;66(3):587-597.
79 Wende AR,Kim J,Holland WL,Wayment BE,O’Neill BT,Tuinei J,Brahma MK,Pepin ME,McCrory MA,Luptak I,Halade GV,Litwin SE,Abel ED.Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.Am JPhysiol Heart Circ Physiol 2017;313(6):H1098-H1108.
80 Szablewski L.Glucose transporters in healthy heart and in cardiac disease.Diabetes 2017;230:70-75.
81 Barone S,Fussell SL,Singh AK,Lucas F,Xu J,Kim C,Wu X,Yu Y,Amlal H,Seidler U,Zuo J,Soleimani M.Slc2a5(Glut5)is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension.JBiol Chem 2009;284(8):5056-5066.
82 Douard V,Ferraris RP.The role of fructose transporters in diseases linked to excessive fructose intake.J Physiol 2013;591(2):401-414.
83 Hamann I,Krys D,Glubrecht D,Bouvet V,Marshall A,Vos L,Mackey JR,Wuest M,Wuest F.Expression and function of hexose transporters GLUT1,GLUT2,and GLUT5 in breast cancer-effects of hypoxia.FASEB J 2018:32(9):5104-5118.
84 Medina Villaamil V,Aparicio Gallego G,Valbuena Rubira L,Garcia Campelo R,Valladares-Ayerbes M,Grande Pulido E,Victoria Bolos M,Santamarina Cainzos I,Anton Aparicio LM.Fructose transporter GLUT5 expression in clear renal cell carcinoma.Oncol Rep 2011;25(2):315-323.
85 Porpaczy E,Bilban M,Heinze G,Gruber M,Vanura K,Schwarzinger I,Stilgenbauer S,Streubel B,Fonatsch C,Jaeger U.Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.Eur J Clin Invest 2009;39(7):568-575.
86 Byrne FL,Olzomer EM,Brink R,Hoehn KL.Knockout of glucose transporter GLUT6 has minimal effects on wholebody metabolic physiology in mice.Am J Physiol Endocrinol Metab 2018;315(2):E286-E293.
87 Byrne FL,Poon IK,Modesitt SC,Tomsig JL,Chow JD,Healy ME,Baker WD,Atkins KA,Lancaster JM,Marchion DC,Moley KH,Ravichandran KS,Slack-Davis JK,Hoehn KL.Metabolic vulnerabilities in endometrial cancer.Cancer Res 2014;74(20):5832-5845.
88 Ebert K,Ewers M,Bisha I,Sander S,Rasputniac T,Daniel H,Antes I,Witt H.Identification of essential amino acids for glucose transporter 5(GLUT5)-mediated fructose transport.J Biol Chem 2018;293(6):2115-2124.
89 Maria Z,Campolo AR,Scherlag BJ,Ritchey JW,Lacombe VA.Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation.Biochim Biophys Acta 2018;1864(4 Pt A):987-996.
90 Murakami R,Chiba Y,Tsuboi K,Matsumoto K,Kawauchi M,Fujihara R,Mashima M,Kanenishi K,Yamamoto T,Ueno M.Immunoreactivity of glucose transporter 8 is localized in the epithelial cells of the choroid plexus and in ependymal cells.Histochem Cell Biol 2016;146(2):231-236.
91 Reagan LP,Rosell DR,Alves SE,Hoskin EK,McCall AL,Charron MJ,McEwen BS.GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus.Brain Res 2002;932(1-2):129-134.
92 Gawlik V,Schmidt S,Scheepers A,Wennemuth G,Augustin R,Aumuller G,Moser M,Al-Hasani H,Kluge R,Joost HG,Schurmann A.Targeted disruption of Slc2a8(GLUT8)reduces motility and mitochondrial potential of spermatozoa.Mol Membr Biol 2008;25(3):224-235.
93 Preitner F,Bonny O,Laverriere A,Rotman S,Firsov D,Da Costa A,Metref S,Thorens B.Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.Proc Natl Acad Sci U S A 2009;106(36):15501-15506.
94 Bibert S,Hess SK,Firsov D,Thorens B,Geering K,Horisberger JD,Bonny O.Mouse GLUT9:evidences for a urate uniporter.Am J Physiol Renal Physiol 2009;297(3):F612-F619.
95 Rizzo M,Obradovic M,Labudovic-Borovic M,Nikolic D,Montalto G,Rizvi AA,Mikhailidis DP,Isenovic ER.Uric acid metabolism in pre-hypertension and the metabolic syndrome.Curr Vasc Pharmacol 2014;12(4):572-585.
96 Feig DI,Kang DH,Johnson RJ.Uric acid and cardiovascular risk.N Engl J Med 2008;359(17):1811-1821.
97 Matsuo H,Chiba T,Nagamori S,Nakayama A,Domoto H,Phetdee K,Wiriyasermkul P,Kikuchi Y,Oda T,Nishiyama J,Nakamura T,Morimoto Y,Kamakura K,Sakurai Y,Nonoyama S,Kanai Y,Shinomiya N.Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.Am JHum Genet 2008;83(6):744-751.
98 Bi M,Jiao Q,Du X,Jiang H.Glut9-mediated urate uptake is responsible for its protective effects on dopaminergic neurons in Parkinson’s disease models.Front Mol Neurosci2018;11:21.
99 Ritelli M,Chiarelli N,Dordoni C,Reffo E,Venturini M,Quinzani S,Monica MD,Scarano G,Santoro G,Russo MG,Calzavara-Pinton P,Milanesi O,Colombi M.Arterial Tortuosity Syndrome:homozygosity for two novel and one recurrent SLC2A10 missense mutations in three families with severe cardiopulmonary complications in infancy and a literature review.BMC Med Genet 2014;15(1):122.
100 Nemeth CE,Marcolongo P,Gamberucci A,Fulceri R,Benedetti A,Zoppi N,Ritelli M,Chiarelli N,Colombi M,Willaert A,Callewaert BL,Coucke PJ,Grof P,Nagy SK,Meszaros T,Banhegyi G,Margittai E.Glucose transporter type 10-lacking in arterial tortuosity syndrome-facilitates dehydroascorbic acid transport.FEBS Lett 2016;590(11):1630-1640.
101 Willaert A,Khatri S,Callewaert BL,Coucke PJ,Crosby SD,Lee JG,Davis EC,Shiva S,Tsang M,De Paepe A,Urban Z.GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFbeta signaling.Hum Mol Genet 2012;21(6):1248-1259.
102 Zoppi N,Chiarelli N,Cinquina V,Ritelli M,Colombi M.GLUT10 deficiency leads to oxidative stress and noncanonical alphavbeta3 integrin-mediated TGFbeta signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts.Hum Mol Genet 2015;24(23):6769-6787.
103 Segade F.Glucose transporter 10 and arterial tortuosity syndrome:the vitamin C connection.FEBS Lett 2010;584(14):2990-2994.
104 Syu YW,Lai HW,Jiang CL,Tsai HY,Lin CC,Lee YC.GLUT10 maintains the integrity of major arteries through regulation of redox homeostasis and mitochondrial function.Hum Mol Genet 2018;27(2):307-321.
105 Jiang YD,Chang YC,Chiu YF,Chang TJ,Li HY,Lin WH,Yuan HY,Chen YT,Chuang LM.SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes.SLC2A10 and PADin type 2 diabetes.BMC Med Genet 2010;11(1):1-7.
106 Gaster M,Handberg A,Schurmann A,Joost HG,Beck-Nielsen H,Schroder HD.GLUT11,but not GLUT8 or GLUT12,is expressed in human skeletal muscle in a fibre type-specific pattern.Pflugers Arch 2004;448(1):105-113.
107 McBrayer SK,Cheng JC,Singhal S,Krett NL,Rosen ST,Shanmugam M.Multiple myeloma exhibits novel dependence on GLUT4,GLUT8,and GLUT11:implications for glucose transporter-directed therapy.Blood 2012;119(20):4686-4697.
108 Matsui C,Takatani-Nakase T,Maeda S,Nakase I,Takahashi K.Potential roles of GLUT12 for glucose sensing and cellular migration in mcf-7 human breast cancer cells under high glucose conditions.Anticancer Res 2017;37(12):6715-6722.
109 Pujol-Gimenez J,de Heredia FP,Idoate MA,Airley R,Lostao MP,Evans AR.Could GLUT12 be a potential therapeutic target in cancer treatment?A preliminary report.JCancer 2015;6(2):139-143.
110 Omurtag K,Esakky P,Debosch BJ,Schoeller EL,Chi MM,Moley KH.Modeling the effect of cigarette smoke on hexose utilization in spermatocytes.Reprod Sci 2015;22(1):94-101.
111 Jimenez-Amilburu V,Jong-Raadsen S,Bakkers J,Spaink HP,Marin-Juez R.GLUT12 deficiency during early development results in heart failure and a diabetic phenotype in zebrafish.J Endocrinol 2015;224(1):1-15.
112 Uldry M,Steiner P,Zurich MG,Beguin P,Hirling H,Dolci W,Thorens B.Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones.EMBO J 2004;23(3):531-540.
113 Bankovic J,Stojsic J,Jovanovic D,Andjelkovic T,Milinkovic V,Ruzdijic S,Tanic N.Identification of genes associated with non-small-cell lung cancer promotion and progression.Lung Cancer 2010;67(2):151-159.
114 Satake W,Nakabayashi Y,Mizuta I,Hirota Y,Ito C,Kubo M,Kawaguchi T,Tsunoda T,Watanabe M,Takeda A,Tomiyama H,Nakashima K,Hasegawa K,Obata F,Yoshikawa T,Kawakami H,Sakoda S,Yamamoto M,Hattori N,Murata M,Nakamura Y,Toda T.Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease.Nat Genet 2009;41(12):1303-1307.
115 Amir Shaghaghi M,Murphy B,Eck P.The SLC2A14 gene:genomic locus,tissue expression,splice variants,and subcellular localization of the protein.Biochem Cell Biol2016;94(4):331-335.
116 Wang W,Yu JT,Zhang W,Cui WZ,Wu ZC,Zhang Q,Tan L.Genetic association of SLC2A14 polymorphism with Alzheimer’s disease in a Han Chinese population.J Mol Neurosci 2012;47(3):481-484.
117 Shi Y,Liu S,Ahmad S,Gao Q.Targeting key transporters in tumor glycolysis as a novel anticancer strategy.Curr Top Med Chem 2018;18(6):454-466.
118 Adekola K,Rosen ST,Shanmugam M.Glucose transporters in cancer metabolism.Curr Opin Oncol 2012;24(6):650-654.
119 Deng D,Xu C,Sun P,Wu J,Yan C,Hu M,Yan N.Crystal structure of the human glucose transporter GLUT1.Nature2014;510(7503):121-125.
120 Deng D,Sun P,Yan C,Ke M,Jiang X,Xiong L,Ren W,Hirata K,Yamamoto M,Fan S,Yan N.Molecular basis of ligand recognition and transport by glucose transporters.Nature 2015;526(7573):391-396.
121 Deng D,Yan N.GLUT,SGLT,and SWEET:Structural and mechanistic investigations of the glucose transporters.Protein Sci 2016;25(3):546-558.
122 Deng D,Yan N.Crystallization and structural determination of the human glucose transporters GLUT1 and GLUT3.Methods Mol Biol 2018;1713:15-29.
2 Thorens B,Mueckler M.Glucose transporters in the 21st century.Am J Physiol Endocrinol Metab 2010;298(2):E141-E145.
3 Mueckler M,Thorens B.The SLC2(GLUT)family of membrane transporters.Mol Aspects Med 2013;34(2-3):121-138.
4 Jaldin-Fincati JR,Pavarotti M,Frendo-Cumbo S,Bilan PJ,Klip A.Update on GLUT4 vesicle traffic:a cornerstone of insulin action.Trends Endocrinol Metab 2017;28(8):597-611.
5 Gamberucci A,Marcolongo P,Nemeth CE,Zoppi N,Szarka A,Chiarelli N,Hegedus T,Ritelli M,Carini G,Willaert A,Callewaert BL,Coucke PJ,Benedetti A,Margittai E,Fulceri R,Banhegyi G,Colombi M.GLUT10-lacking in arterial tortuosity syndrome-is localized to the endoplasmic reticulum of human fibroblasts.Int J Mol Sci 2017;18(8).pii:E1820.doi:10.3390/ijms18081820.
6 Mueckler M.Facilitative glucose transporters.Eur JBiochem 1994;219(3):713-725.
7 Ge X,Chen C,Hui X,Wang Y,Lam KS,Xu A.Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes.J Biol Chem 2011;286(40):34533-34541.
8 Lu CS,Ye RG,Yang QQ,Yang X,Li HQ,Li YJ.Gene expression of glucose transports and its regulation by glucose in mesothelial cells.Chin Med J 2001;114(5):477-480.
9 Hsieh IS,Yang RS,Fu WM.Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.PLoS One 2014;9(10):e109550.
10 Romero R,Casanova B,Pulido N,Suarez AI,Rodriguez E,Rovira A.Stimulation of glucose transport by thyroid hormone in 3T3-L1 adipocytes:increased abundance of GLUT1 and GLUT4 glucose transporter proteins.J Endocrinol 2000;164(2):187-195.
11 Huang Y,Lei L,Liu D,Jovin I,Russell R,Johnson RS,Di Lorenzo A,Giordano FJ.Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1alphad e pendent function.Proc Natl Acad Sci U S A 2012;109(43):17478-17483.
12 Chiou GY,Fong JC.Prostaglandin F2alpha increases glucose transport in 3T3-L1 adipocytes through enhanced GLUT1 expression by a protein kinase C-dependent pathway.Cell Signal 2004;16(4):415-421.
13 Hiraki Y,McMorrow IM,Birnbaum MJ.The regulation of glucose transporter gene expression by cyclic adenosine monophosphate in NIH3T3 fibroblasts.Mol Endocrinol1989;3(9):1470-1476.
14 Mountjoy KG,Flier JS.Vanadate regulates glucose transporter(Glut-1)expression in NIH3T3 mouse fibroblasts.Endocrinology 1990;127(4):2025-2034.
15 Rollins BJ,Morrison ED,Usher P,Flier JS.Platelet-derived growth factor regulates glucose transporter expression.JBiol Chem 1988;263(32):16523-16526.
16 Takano M,Rhoads DB,Isselbacher KJ.Sodium butyrate increases glucose transporter expression in LLC-PK1 cells.Proc Natl Acad Sci U S A 1988;85(21):8072-8075.
17 Diaz M,Vraskou Y,Gutierrez J,Planas JV.Expression of rainbow trout glucose transporters GLUT1 and GLUT4during in vitro muscle cell differentiation and regulation by insulin and IGF-I.Am J Physiol Regul Integr Comp Physiol2009;296(3):R794-R800.
18 Tordjman KM,Leingang KA,James DE,Mueckler MM.Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes:effect of chronic insulin and tolbutamide treatment.Proc Natl Acad Sci U S A1989;86(20):7761-7765.
19 Tai PK,Liao JF,Chen EH,Dietz J,Schwartz J,Carter-Su C.Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells.J Biol Chem 1990;265(35):21828-21834.
20 Stephens JM,Carter BZ,Pekala PH,Malter JS.Tumor necrosis factor alpha-induced glucose transporter(GLUT-1)mRNA stabilization in 3T3-L1 preadipocytes.Regulation by the adenosine-uridine binding factor.J Biol Chem 1992;267(12):8336-8341.
21 Spolcova A,Holubova M,Mikulaskova B,Nagelova V,Stofkova A,Lacinova Z,Jurcovicova J,Haluzik M,Maletinska L,Zelezna B.Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes.Physiol Res 2014;63(4):483-490.
22 Nagai K,Inoue T,Konishi H.Increased gene expression of glucose transporters in the mouse brain after treatment with fluoxetine and pergolide.Drug Res(Stuttg)2014;64(7):389-391.
23 Walker PS,Ramlal T,Donovan JA,Doering TP,Sandra A,Klip A,Pessin JE.Insulin and glucose-dependent regulation of the glucose transport system in the rat L6 skeletal muscle cell line.J Biol Chem 1989;264(11):6587-6595.
24 Schwartzenberg-Bar-Yoseph F,Armoni M,Karnieli E.The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.Cancer Res 2004;64(7):2627-2633.
25 Delahayes JF.Depolarization-induced movement of Mn 2cations across the cell membrane in the guinea pig myocardium.Circ Res 1975;36(6):713-718.
26 Narasimhan A,Chinnaiyan M,Karundevi B.Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat.Eur J Pharmacol 2015;761:391-397.
27 Postic C,Burcelin R,Rencurel F,Pegorier JP,Loizeau M,Girard J,Leturque A.Evidence for a transient inhibitory effect of insulin on GLUT2 expression in the liver:studies in vivo and in vitro.Biochem J 1993;293(Pt 1):119-124.
28 Simpson IA,Dwyer D,Malide D,Moley KH,Travis A,Vannucci SJ.The facilitative glucose transporter GLUT3:20 years of distinction.Am J Physiol Endocrinol Metab2008;295(2):E242-E253.
29 Hu H,Xu M,Qi R,Wang Y,Wang C,Liu J,Luo L,Xia L,Fang Z.Sitagliptin downregulates retinol-binding protein 4and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.Int J Clin Exp Med2015;8(10):17902-17911.
30 Armoni M,Harel C,Ramdas M,Karnieli E.CYP2E1impairs GLUT4 gene expression and function:NRF2 as a possible mediator.Horm Metab Res 2014;46(7):477-483.
31 Matosin-Matekalo M,Mesonero JE,Laroche TJ,Lacasa M,Brot-Laroche E.Glucose and thyroid hormone co-regulate the expression of the intestinal fructose transporter GLUT5.Biochem J 1999;339(Pt 2):233-239.
32 Nilsson TH,Richmond CF,Nelson TM.Flicker adaptation shows evidence of many visual channels selectively sensitive to temporal frequency.Vision Res 1975;15(5):621-624.
33 Stuart CA,Howell ME,Yin D.Overexpression of GLUT5in diabetic muscle is reversed by pioglitazone.Diabetes Care 2007;30(4):925-931.
34 Douard V,Ferraris RP.Regulation of the fructose transporter GLUT5 in health and disease.Am J Physiol Endocrinol Metab 2008;295(2):E227-E237.
35 Kim E,Seok HH,Lee SY,Lee DR,Moon J,Yoon TK,Lee WS,Lee KA.Correlation between expression of glucose transporters in granulosa cells and oocyte quality in women with polycystic ovary syndrome.Endocrinol Metab(Seoul)2014;29(1):40-47.
36 Cheeseman C.GLUT7:a new intestinal facilitated hexose transporter.Am J Physiol Endocrinol Metab 2008;295(2):E238-E241.
37 Ibberson M,Riederer BM,Uldry M,Guhl B,Roth J,Thorens B.Immunolocalization of GLUTX1 in the testis and to specific brain areas and vasopressin-containing neurons.Endocrinology 2002;143(1):276-284.
38 Mayer AL,Higgins CB,Heitmeier MR,Kraft TE,Qian X,Crowley JR,Hyrc KL,Beatty WL,Yarasheski KE,Hruz PW,DeBosch BJ.SLC2A8(GLUT8)is a mammalian trehalose transporter required for trehalose-induced autophagy.Sci Rep 2016;6:38586.
39 Schmidt S,Joost HG,Schurmann A.GLUT8,the enigmatic intracellular hexose transporter.Am J Physiol Endocrinol Metab 2009;296(4):E614-E618.
40 Joost HG,Thorens B.The extended GLUT-family of sugar/polyol transport facilitators:nomenclature,sequence characteristics,and potential function of its novel members(review).Mol Membr Biol 2001;18(4):247-256.
41 Kimura T,Takahashi M,Yan K,Sakurai H.Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells.PLoS One 2014;9(1):e84996.
42 Carayannopoulos MO,Schlein A,Wyman A,Chi M,Keembiyehetty C,Moley KH.GLUT9 is differentially expressed and targeted in the preimplantation embryo.Endocrinology2004;145(3):1435-1443.
43 Zhu C,Xu Y,Liu ZH,Wan XC,Li DX,Tai LL.The anti-hyperuricemic effect of epigallocatechin-3-gallate(EGCG)on hyperuricemic mice.Biomed Pharmacother2018;97:168-173.
44 Pujol-Gimenez J,Perez A,Reyes AM,Loo DD,Lostao MP.Functional characterization of the human facilitative glucose transporter 12(GLUT12)by electrophysiological methods.Am J Physiol Cell Physiol 2015;308(12):C1008-C1022.
45 Rogers S,Macheda ML,Docherty SE,Carty MD,Henderson MA,Soeller WC,Gibbs EM,James DE,Best JD.Identification of a novel glucose transporter-like protein-GLUT-12.Am J Physiol Endocrinol Metab 2002;282(3):E733-E738.
46 White MA,Tsouko E,Lin C,Rajapakshe K,Spencer JM,Wilkenfeld SR,Vakili SS,Pulliam TL,Awad D,Nikolos F,Katreddy RR,Kaipparettu BA,Sreekumar A,Zhang X,Cheung E,Coarfa C,Frigo DE.GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaM-KK2 signaling.Endocr Relat Cancer 2018;25(4):453-469.
47 Wu X,Freeze HH.GLUT14,a duplicon of GLUT3,is specifically expressed in testis as alternative splice forms.Genomics 2002;80(6):553-557.
48 Manel N,Kim FJ,Kinet S,Taylor N,Sitbon M,Battini JL.The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.Cell 2003;115(4):449-459.
49 Macintyre AN,Gerriets VA,Nichols AG,Michalek RD,Rudolph MC,Deoliveira D,Anderson SM,Abel ED,Chen BJ,Hale LP,Rathmell JC.The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.Cell Metab 2014;20(1):61-72.
50 Ji XN(姬辛娜),Xu CJ,Gao ZJ,Chen SH,Xu KM,Chen Q.Glucose transporter 1 deficiency syndrome:features of movement disorders,diagnosis and treatment.Chin JContemp Pediatr(中国当代儿科杂志)2018;20(3):209-213(in Chinese with English abstract).
51 Winkler EA,Nishida Y,Sagare AP,Rege SV,Bell RD,Perlmutter D,Sengillo JD,Hillman S,Kong P,Nelson AR,Sullivan JS,Zhao Z,Meiselman HJ,Wendy RB,Soto J,Abel ED,Makshanoff J,Zuniga E,De Vivo DC,Zlokovic BV.GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration.Nat Neurosci2015;18(4):521-530.
52 Deng Y,Li B,Liu Y,Iqbal K,Grundke-Iqbal I,Gong CX.Dysregulation of insulin signaling,glucose transporters,O-GlcNAcylation,and phosphorylation of tau and neurofilaments in the brain:Implication for Alzheimer’s disease.Am J Pathol 2009;175(5):2089-2098.
53 Wang BY,Kalir T,Sabo E,Sherman DE,Cohen C,Burstein DE.Immunohistochemical staining of GLUT1 in benign,hyperplastic,and malignant endometrial epithelia.Cancer2000;88(12):2774-2781.
54 Sasaki H,Shitara M,Yokota K,Hikosaka Y,Moriyama S,Yano M,Fujii Y.Overexpression of GLUT1 correlates with Kras mutations in lung carcinomas.Mol Med Rep 2012;5(3):599-602.
55 Suganuma N,Segade F,Matsuzu K,Bowden DW.Differential expression of facilitative glucose transporters in normal and tumour kidney tissues.BJU Int 2007;99(5):1143-1149.
56 Kapoor S.Glucose transporter 1(GLUT1)and its emerging role as a significant prognostic marker in systemic malignancies.Int J Colorectal Dis 2013;28(9):1317-1318.
57 Saigusa S,Toiyama Y,Tanaka K,Okugawa Y,Fujikawa H,Matsushita K,Uchida K,Inoue Y,Kusunoki M.Prognostic significance of glucose transporter-1(GLUT1)gene expression in rectal cancer after preoperative chemoradiotherapy.Surg Today 2012;42(5):460-469.
58 Hodgkinson AD,Millward BA,Demaine AG.Polymorphisms of the glucose transporter(GLUT1)gene are associated with diabetic nephropathy.Kidney Int 2001;59(3):985-989.
59 Fernandes R,Carvalho AL,Kumagai A,Seica R,Hosoya K,Terasaki T,Murta J,Pereira P,Faro C.Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.Mol Vis2004;10(74-75):618-628.
60 Garg M,Thamotharan M,Becker DJ,Devaskar SU.Adolescents with clinical type 1 diabetes display reduced red blood cell glucose transporter isoform 1(GLUT1).Pediatr Diabetes 2014;15(7):511-518.
61 Kellett GL,Brot-Laroche E,Mace OJ,Leturque A.Sugar absorption in the intestine:the role of GLUT2.Annu Rev Nutr 2008;28:35-54.
62 Kehar M,Bijarnia S,Ellard S,Houghton J,Saxena R,Verma IC,Wadhwa N.Fanconi-Bickel syndrome-mutation in SLC2A2 gene.Indian J Pediatr 2014;81(11):1237-1239.
63 Santer R,Steinmann B,Schaub J.Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport.Curr Mol Med 2002;2(2):213-227.
64 Shi PP(史佩佩),Wang M,Dou WJ.Fanconi-Bickel syndrome with SLC2A2 gene mutation in a child.Chin JPediatr(中华儿科杂志)2018;56(1):65-66(in Chinese with English abstract).
65 Chankiewitz E,Peschke D,Herberg L,Bazwinsky I,Muhlbauer E,Bromme HJ,Peschke E.Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse(NZO/Hl)?Exp Clin Endocrinol Diabetes 2006;114(5):262-269.
66 Kiraly MA,Bates HE,Kaniuk NA,Yue JT,Brumell JH,Matthews SG,Riddell MC,Vranic M.Swim training prevents hyperglycemia in ZDF rats:mechanisms involved in the partial maintenance of beta-cell function.Am J Physiol Endocrinol Metab 2008;294(2):E271-E283.
67 Frese T,Bazwinsky I,Muhlbauer E,Peschke E.Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats.Horm Metab Res 2007;39(8):567-574.
68 Agostini M,Romeo F,Inoue S,Niklison-Chirou MV,Elia AJ,Dinsdale D,Morone N,Knight RA,Mak TW,Melino G.Metabolic reprogramming during neuronal differentiation.Cell Death Differ 2016;23(9):1502-1514.
69 Morea V,Bidollari E,Colotti G,Fiorillo A,Rosati J,De Filippis L,Squitieri F,Ilari A.Glucose transportation in the brain and its impairment in Huntington disease:one more shade of the energetic metabolism failure?Amino Acids2017;49(7):1147-1157.
70 Vittori A,Breda C,Repici M,Orth M,Roos RA,Outeiro TF,Giorgini F,Hollox EJ.Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington’s disease.Hum Mol Genet 2014;23(12):3129-3137.
71 Covarrubias-Pinto A,Moll P,Solis-Maldonado M,Acuna AI,Riveros A,Miro MP,Papic E,Beltran FA,Cepeda C,Concha,II,Brauchi S,Castro MA.Beyond the redox imbalance:Oxidative stress contributes to an impaired GLUT3modulation in Huntington’s disease.Free Radic Biol Med2015;89:1085-1096.
72 Szablewski L.Glucose transporters in brain:in health and in Alzheimer’s disease.J Alzheimers Dis 2017;55(4):1307-1320.
73 An Y,Varma VR,Varma S,Casanova R,Dammer E,Pletnikova O,Chia CW,Egan JM,Ferrucci L,Troncoso J,Levey AI,Lah J,Seyfried NT,Legido-Quigley C,O’Brien R,Thambisetty M.Evidence for brain glucose dysregulation in Alzheimer’s disease.Alzheimers Dement 2018;14(3):318-329.
74 James DE,Brown R,Navarro J,Pilch PF.Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein.Nature 1988;333(6169):183-185.
75 Zong H,Wang CC,Vaitheesvaran B,Kurland IJ,Hong W,Pessin JE.Enhanced energy expenditure,glucose utilization,and insulin sensitivity in VAMP8 null mice.Diabetes2011;60(1):30-38.
76 Stenbit AE,Tsao TS,Li J,Burcelin R,Geenen DL,Factor SM,Houseknecht K,Katz EB,Charron MJ.GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes.Nat Med 1997;3(10):1096-1101.
77 Klip A.The many ways to regulate glucose transporter 4.Appl Physiol Nutr Metab 2009;34(3):481-487.
78 Reno CM,Puente EC,Sheng Z,Daphna-Iken D,Bree AJ,Routh VH,Kahn BB,Fisher SJ.Brain GLUT4 knockout mice have impaired glucose tolerance,decreased insulin sensitivity,and impaired hypoglycemic counterregulation.Diabetes 2017;66(3):587-597.
79 Wende AR,Kim J,Holland WL,Wayment BE,O’Neill BT,Tuinei J,Brahma MK,Pepin ME,McCrory MA,Luptak I,Halade GV,Litwin SE,Abel ED.Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.Am JPhysiol Heart Circ Physiol 2017;313(6):H1098-H1108.
80 Szablewski L.Glucose transporters in healthy heart and in cardiac disease.Diabetes 2017;230:70-75.
81 Barone S,Fussell SL,Singh AK,Lucas F,Xu J,Kim C,Wu X,Yu Y,Amlal H,Seidler U,Zuo J,Soleimani M.Slc2a5(Glut5)is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension.JBiol Chem 2009;284(8):5056-5066.
82 Douard V,Ferraris RP.The role of fructose transporters in diseases linked to excessive fructose intake.J Physiol 2013;591(2):401-414.
83 Hamann I,Krys D,Glubrecht D,Bouvet V,Marshall A,Vos L,Mackey JR,Wuest M,Wuest F.Expression and function of hexose transporters GLUT1,GLUT2,and GLUT5 in breast cancer-effects of hypoxia.FASEB J 2018:32(9):5104-5118.
84 Medina Villaamil V,Aparicio Gallego G,Valbuena Rubira L,Garcia Campelo R,Valladares-Ayerbes M,Grande Pulido E,Victoria Bolos M,Santamarina Cainzos I,Anton Aparicio LM.Fructose transporter GLUT5 expression in clear renal cell carcinoma.Oncol Rep 2011;25(2):315-323.
85 Porpaczy E,Bilban M,Heinze G,Gruber M,Vanura K,Schwarzinger I,Stilgenbauer S,Streubel B,Fonatsch C,Jaeger U.Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12.Eur J Clin Invest 2009;39(7):568-575.
86 Byrne FL,Olzomer EM,Brink R,Hoehn KL.Knockout of glucose transporter GLUT6 has minimal effects on wholebody metabolic physiology in mice.Am J Physiol Endocrinol Metab 2018;315(2):E286-E293.
87 Byrne FL,Poon IK,Modesitt SC,Tomsig JL,Chow JD,Healy ME,Baker WD,Atkins KA,Lancaster JM,Marchion DC,Moley KH,Ravichandran KS,Slack-Davis JK,Hoehn KL.Metabolic vulnerabilities in endometrial cancer.Cancer Res 2014;74(20):5832-5845.
88 Ebert K,Ewers M,Bisha I,Sander S,Rasputniac T,Daniel H,Antes I,Witt H.Identification of essential amino acids for glucose transporter 5(GLUT5)-mediated fructose transport.J Biol Chem 2018;293(6):2115-2124.
89 Maria Z,Campolo AR,Scherlag BJ,Ritchey JW,Lacombe VA.Dysregulation of insulin-sensitive glucose transporters during insulin resistance-induced atrial fibrillation.Biochim Biophys Acta 2018;1864(4 Pt A):987-996.
90 Murakami R,Chiba Y,Tsuboi K,Matsumoto K,Kawauchi M,Fujihara R,Mashima M,Kanenishi K,Yamamoto T,Ueno M.Immunoreactivity of glucose transporter 8 is localized in the epithelial cells of the choroid plexus and in ependymal cells.Histochem Cell Biol 2016;146(2):231-236.
91 Reagan LP,Rosell DR,Alves SE,Hoskin EK,McCall AL,Charron MJ,McEwen BS.GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus.Brain Res 2002;932(1-2):129-134.
92 Gawlik V,Schmidt S,Scheepers A,Wennemuth G,Augustin R,Aumuller G,Moser M,Al-Hasani H,Kluge R,Joost HG,Schurmann A.Targeted disruption of Slc2a8(GLUT8)reduces motility and mitochondrial potential of spermatozoa.Mol Membr Biol 2008;25(3):224-235.
93 Preitner F,Bonny O,Laverriere A,Rotman S,Firsov D,Da Costa A,Metref S,Thorens B.Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.Proc Natl Acad Sci U S A 2009;106(36):15501-15506.
94 Bibert S,Hess SK,Firsov D,Thorens B,Geering K,Horisberger JD,Bonny O.Mouse GLUT9:evidences for a urate uniporter.Am J Physiol Renal Physiol 2009;297(3):F612-F619.
95 Rizzo M,Obradovic M,Labudovic-Borovic M,Nikolic D,Montalto G,Rizvi AA,Mikhailidis DP,Isenovic ER.Uric acid metabolism in pre-hypertension and the metabolic syndrome.Curr Vasc Pharmacol 2014;12(4):572-585.
96 Feig DI,Kang DH,Johnson RJ.Uric acid and cardiovascular risk.N Engl J Med 2008;359(17):1811-1821.
97 Matsuo H,Chiba T,Nagamori S,Nakayama A,Domoto H,Phetdee K,Wiriyasermkul P,Kikuchi Y,Oda T,Nishiyama J,Nakamura T,Morimoto Y,Kamakura K,Sakurai Y,Nonoyama S,Kanai Y,Shinomiya N.Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.Am JHum Genet 2008;83(6):744-751.
98 Bi M,Jiao Q,Du X,Jiang H.Glut9-mediated urate uptake is responsible for its protective effects on dopaminergic neurons in Parkinson’s disease models.Front Mol Neurosci2018;11:21.
99 Ritelli M,Chiarelli N,Dordoni C,Reffo E,Venturini M,Quinzani S,Monica MD,Scarano G,Santoro G,Russo MG,Calzavara-Pinton P,Milanesi O,Colombi M.Arterial Tortuosity Syndrome:homozygosity for two novel and one recurrent SLC2A10 missense mutations in three families with severe cardiopulmonary complications in infancy and a literature review.BMC Med Genet 2014;15(1):122.
100 Nemeth CE,Marcolongo P,Gamberucci A,Fulceri R,Benedetti A,Zoppi N,Ritelli M,Chiarelli N,Colombi M,Willaert A,Callewaert BL,Coucke PJ,Grof P,Nagy SK,Meszaros T,Banhegyi G,Margittai E.Glucose transporter type 10-lacking in arterial tortuosity syndrome-facilitates dehydroascorbic acid transport.FEBS Lett 2016;590(11):1630-1640.
101 Willaert A,Khatri S,Callewaert BL,Coucke PJ,Crosby SD,Lee JG,Davis EC,Shiva S,Tsang M,De Paepe A,Urban Z.GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFbeta signaling.Hum Mol Genet 2012;21(6):1248-1259.
102 Zoppi N,Chiarelli N,Cinquina V,Ritelli M,Colombi M.GLUT10 deficiency leads to oxidative stress and noncanonical alphavbeta3 integrin-mediated TGFbeta signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts.Hum Mol Genet 2015;24(23):6769-6787.
103 Segade F.Glucose transporter 10 and arterial tortuosity syndrome:the vitamin C connection.FEBS Lett 2010;584(14):2990-2994.
104 Syu YW,Lai HW,Jiang CL,Tsai HY,Lin CC,Lee YC.GLUT10 maintains the integrity of major arteries through regulation of redox homeostasis and mitochondrial function.Hum Mol Genet 2018;27(2):307-321.
105 Jiang YD,Chang YC,Chiu YF,Chang TJ,Li HY,Lin WH,Yuan HY,Chen YT,Chuang LM.SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes.SLC2A10 and PADin type 2 diabetes.BMC Med Genet 2010;11(1):1-7.
106 Gaster M,Handberg A,Schurmann A,Joost HG,Beck-Nielsen H,Schroder HD.GLUT11,but not GLUT8 or GLUT12,is expressed in human skeletal muscle in a fibre type-specific pattern.Pflugers Arch 2004;448(1):105-113.
107 McBrayer SK,Cheng JC,Singhal S,Krett NL,Rosen ST,Shanmugam M.Multiple myeloma exhibits novel dependence on GLUT4,GLUT8,and GLUT11:implications for glucose transporter-directed therapy.Blood 2012;119(20):4686-4697.
108 Matsui C,Takatani-Nakase T,Maeda S,Nakase I,Takahashi K.Potential roles of GLUT12 for glucose sensing and cellular migration in mcf-7 human breast cancer cells under high glucose conditions.Anticancer Res 2017;37(12):6715-6722.
109 Pujol-Gimenez J,de Heredia FP,Idoate MA,Airley R,Lostao MP,Evans AR.Could GLUT12 be a potential therapeutic target in cancer treatment?A preliminary report.JCancer 2015;6(2):139-143.
110 Omurtag K,Esakky P,Debosch BJ,Schoeller EL,Chi MM,Moley KH.Modeling the effect of cigarette smoke on hexose utilization in spermatocytes.Reprod Sci 2015;22(1):94-101.
111 Jimenez-Amilburu V,Jong-Raadsen S,Bakkers J,Spaink HP,Marin-Juez R.GLUT12 deficiency during early development results in heart failure and a diabetic phenotype in zebrafish.J Endocrinol 2015;224(1):1-15.
112 Uldry M,Steiner P,Zurich MG,Beguin P,Hirling H,Dolci W,Thorens B.Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones.EMBO J 2004;23(3):531-540.
113 Bankovic J,Stojsic J,Jovanovic D,Andjelkovic T,Milinkovic V,Ruzdijic S,Tanic N.Identification of genes associated with non-small-cell lung cancer promotion and progression.Lung Cancer 2010;67(2):151-159.
114 Satake W,Nakabayashi Y,Mizuta I,Hirota Y,Ito C,Kubo M,Kawaguchi T,Tsunoda T,Watanabe M,Takeda A,Tomiyama H,Nakashima K,Hasegawa K,Obata F,Yoshikawa T,Kawakami H,Sakoda S,Yamamoto M,Hattori N,Murata M,Nakamura Y,Toda T.Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease.Nat Genet 2009;41(12):1303-1307.
115 Amir Shaghaghi M,Murphy B,Eck P.The SLC2A14 gene:genomic locus,tissue expression,splice variants,and subcellular localization of the protein.Biochem Cell Biol2016;94(4):331-335.
116 Wang W,Yu JT,Zhang W,Cui WZ,Wu ZC,Zhang Q,Tan L.Genetic association of SLC2A14 polymorphism with Alzheimer’s disease in a Han Chinese population.J Mol Neurosci 2012;47(3):481-484.
117 Shi Y,Liu S,Ahmad S,Gao Q.Targeting key transporters in tumor glycolysis as a novel anticancer strategy.Curr Top Med Chem 2018;18(6):454-466.
118 Adekola K,Rosen ST,Shanmugam M.Glucose transporters in cancer metabolism.Curr Opin Oncol 2012;24(6):650-654.
119 Deng D,Xu C,Sun P,Wu J,Yan C,Hu M,Yan N.Crystal structure of the human glucose transporter GLUT1.Nature2014;510(7503):121-125.
120 Deng D,Sun P,Yan C,Ke M,Jiang X,Xiong L,Ren W,Hirata K,Yamamoto M,Fan S,Yan N.Molecular basis of ligand recognition and transport by glucose transporters.Nature 2015;526(7573):391-396.
121 Deng D,Yan N.GLUT,SGLT,and SWEET:Structural and mechanistic investigations of the glucose transporters.Protein Sci 2016;25(3):546-558.
122 Deng D,Yan N.Crystallization and structural determination of the human glucose transporters GLUT1 and GLUT3.Methods Mol Biol 2018;1713:15-29.